Form 4 holding
Director
ALNYLAM PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 2,000
- Estimated value
- $661,740
- Report date
- 20 May 2026
- Price
- $330.87
- Ownership
- by Trust
Charles Elliott Sigal - Director at ALNYLAM PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ALNY on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Charles Elliott Sigal since 27 Jun 2025
Reported holdings for Charles Elliott Sigal in ALNYLAM PHARMACEUTICALS, INC.
Form 4 holding
Director
ALNYLAM PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 1,446
- Estimated value
- $478,438
- Report date
- 20 May 2026
- Price
- $330.87
- Ownership
- Direct
Form 4 holding
Director
ALNYLAM PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 1,441
- Estimated value
- Report date
- 20 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Charles Elliott Sigal in ALNYLAM PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.